Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

General disorders and administration site conditions – page 8

  • 140 clinical trials
  • 58 recruiting
  • 120 conditions
  • 23 countries

Conditions in this area

120 conditions with trials, the busiest first

Procedural pain29Pain21Critical illness18Medical device site joint infection8Inflammation7Still's disease6Chronic fatigue syndrome5Friedreich's ataxia5Cachexia4Device related infection4Hereditary ataxia4Hot flush4Postoperative analgesia4Anxiety2Colorectal cancer2Delirium tremens2Diabetic neuropathy2Febrile neutropenia2Hip arthroplasty2Juvenile idiopathic arthritis2Menopausal symptoms2Neuropathy peripheral2Parkinson's disease2Pyrexia2+96

Clinical trials in General disorders and administration site conditions

140 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

140 clinical trials

Cerebellar ataxia

Not yet recruiting

Study on the Effects of Ubiquinol and Ascorbic Acid for Patients with Mitochondrial Disorders and Cerebellar Ataxias

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Fundacio Sant Joan De Deu

Procedural pain

Not yet recruiting

Study on Pain Relief After Breast Cancer Surgery: Comparing Liposomal Bupivacaine and Levobupivacaine in Patients Undergoing Mastectomy

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bupivacaine
  • Sponsor:St Antonius Hospital

Critical illness

Not yet recruiting

Study on the Effects of Antibiotic Monitoring in ICU Patients Using Meropenem and Drug Combination

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cefepime
  • Sponsor:Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau

Hot flush

Not recruiting

Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Fezolinetant
  • Sponsor:Astellas Pharma Global Development Inc.

Hereditary ataxia

Not recruiting

Safety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Pain+1

Not recruiting

A study to compare how the body absorbs celecoxib oral suspension and celecoxib capsules in healthy adults for the treatment of acute pain.

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · Healthy volunteers
  • Substances:Celecoxib
  • Sponsor:Codadose Inc.

Testosterone deficiency syndrome+2

Not recruiting

Bioavailability, Safety and Tolerability of elinzanetant (BAY 3427080) in Healthy Adults for Treatment of Vasomotor Symptoms

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG

Pain

Not recruiting

Safety, Tolerability and Pharmacokinetics of MK-4318 in Healthy Adult Participants for Acute and Chronic Pain

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Merck Sharp & Dohme LLC

Inflammation

Not recruiting

A study to evaluate how JNJ-77242113 is absorbed by the body in healthy participants for the treatment of inflammatory diseases.

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Janssen Cilag International

Testosterone deficiency syndrome+2

Not recruiting

Relative bioavailability and safety of elinzanetant soft‑gel capsules in healthy adults for vasomotor symptoms

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG

Pain

Not recruiting

Safety, Tolerability and Pharmacokinetics of MK-4318 in Healthy Adults with Pain

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Merck Sharp & Dohme LLC

Anxiety+1

Not recruiting

Comparison of oxazepam 50 mg orodispersible tablets and oxazepam 50 mg standard tablets in healthy volunteers to test if they work the same way in the body

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Oxazepam
  • Sponsor:Neuraxpharm Pharmaceuticals S.L.

Substances studied in this area

The therapies tested most often in General disorders and administration site conditions trials.

Sodium Chloride18 clinical trialsParacetamol10 clinical trialsIbuprofen5 clinical trialsLidocaine Hydrochloride5 clinical trialsPlacebo5 clinical trialsRifampicin5 clinical trialsLidocaine Hydrochloride Monohydrate4 clinical trialsLinezolid4 clinical trialsPiperacillin4 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.